Joanne Sloan‐Lancaster

Author

Eli Lilly (United States)

Also Known As

J SLOANLANCASTER, Joanne Sloan-Lancaster, Joanne Sloan‐Lancaster

Publications

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)National Institutes of Health Washington University in St. Louis

About

Joanne Sloan‐Lancaster is an author at Eli Lilly (United States) specializing in medicine, cell biology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.2K
2	Cell Biology	3	3	1.2K
3	Immunology	2	2	1.2K
4	Natural Sciences	1	1	47
5	Cellular Physiology	1	1	47

Joanne Sloan‐Lancaster

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
LAT Joanne Sloan‐Lancaster, J. Kitchen, Ronald P. Trible, Cell	1998	1.3K
Partial T cell signaling: Altered phospho-? and lack of zap70 recruitment in APL-induced T cell anergy Joanne Sloan‐Lancaster Cell Partial T CellSignal TransductionAutoimmune DiseaseMolecular PhysiologyZap70 Recruitment	1994	594
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells Joanne Sloan‐Lancaster, Brian D. Evavold, Paul M. Allen Nature Autoimmune DiseaseT-regulatory CellImmunologyLive Antigen-presenting CellsAltered T-cell-receptor Ligand	1993	589
Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes Joanne Sloan‐Lancaster, Eyas Abu-Raddad, John Polzer, Diabetes Care	2013	178
ZAP-70 Association with T Cell Receptor ζ (TCRζ): Fluorescence Imaging of Dynamic Changes upon Cellular Stimulation Joanne Sloan‐Lancaster, John F. Presley, Jan Ellenberg, The Journal of Cell Biology	1998	65
Regulation of ZAP-70 Intracellular Localization: Visualization with the Green Fluorescent Protein Joanne Sloan‐Lancaster, Weiguo Zhang, John F. Presley, The Journal of Experimental Medicine Cellular DynamicsMolecular BiologyGreen Fluorescent ProteinSignal RecognitionCytoskeleton	1997	47
LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase Joanne Sloan‐Lancaster, Eyas Raddad, Amy Flynt, Journal of the Renin-Angiotensin-Aldosterone System	2017	38
Determination of the Mechanism of Action of Anti-FasL Antibody by Epitope Mapping and Homology Modeling Victor H. Obungu, Valentina Gelfanova, Radhakrishnan Rathnachalam, Biochemistry	2009	25
Population Pharmacokinetic Modeling of LY2189102 after Multiple Intravenous and Subcutaneous Administrations Sébastien Bihorel, Jill Fiedler‐Kelly, Elizabeth Ludwig, The AAPS Journal Subcutaneous AdministrationsMultiple IntravenousPharmacokinetic ModelingMedicinePopulation Pharmacokinetic Modeling	2014	15

Page 1